Orion Corporation (Finland)

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial

Ferenc Folláth, H. Just, JGY Papp et al. · The Lancet · 2002 · 1.2K citations

Lido Study, Intravenous Levosimendan, Heart Failure +10

Kinetics of Human Soluble and Membrane-Bound Catechol O-Methyltransferase: A Revised Mechanism and Description of the Thermolabile Variant of the Enzyme

Timo Lotta, Jukka Vidgren, Carola Tilgmann et al. · Biochemistry · 1995 · 1.2K citations

Factors predictive of the development of Levodopa‐induced dyskinesia and wearing‐off in Parkinson's disease

C. Warren Olanow, Karl Kieburtz, Olivier Rascol et al. · Movement Disorders · 2013 · 455 citations

Kinesiology, Health Sciences, Parkinson Disease +13

Crystal structure of catechol O-methyltransferase

Jukka Vidgren, L.A. Svensson, Anders Liljas · Nature · 1994 · 433 citations

Crystal Structure, Structure Elucidation, Biochemistry

Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure

Milton Packer, Wilson S. Colucci, Lloyd D. Fisher et al. · JACC Heart Failure · 2013 · 429 citations

Heart Failure, Cardiogenic Shock, Cardiovascular Disease +7